Sort
15,842 grants matching “pancreatic cancer”
Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer
$355,739Satyanarayana Rachagani · University Of Missouri-Columbia · R01 · FY2024 · CA
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$355,646Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2016 · CA
TGF-beta Signaling in Pancreatic Cancer
$355,576Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2008 · CA
Generating CTL Against Tumor Associated Peptide Antigens
$355,534Scripps Research Institute · R01 · FY2005 · CA
Computational Biology
$355,527Byungkook Lee · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Combination therapy to inhibit neuroblastoma growth
$355,503Jasti S Rao · University Of Illinois At Chicago · R01 · FY2012 · CA
Combination therapy to inhibit neuroblastoma growth
$355,503Jasti S Rao · University Of Illinois At Chicago · R01 · FY2011 · CA
Origins and functions of pancreatic cancer-associated fibroblasts
$355,498Mara H. Sherman · Oregon Health & Science University · R01 · FY2021 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$355,406Dartmouth College · R01 · FY2005 · CA
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer
$355,328Chang-Il Hwang · University Of California At Davis · R37 · FY2022 · CA
PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia
$355,258Teresa A Zimmers · Indiana University Indianapolis · R01 · FY2017 · CA
Novel Approaches for Pancreatic Cancer Therapy
$355,239Paul B Fisher · Columbia University Health Sciences · R01 · FY2006 · CA
SLC6A14 as a unique drug target to treat pancreatic cancer
$355,096Yangzom Doma Bhutia · Texas Tech University Health Scis Center · R01 · FY2023 · CA
Computational Models of the Human Cell Cycle to Reveal Disease Mechanism and Inform Treatment
$355,036Jeremy Purvis · Univ Of North Carolina Chapel Hill · R01 · FY2021 · GM
Integrated Signaling in Pancreatic Cancer Progression
$355,019Robert S Bresalier · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
$355,019Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis
$355,019Huamin Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer
$354,974Chang-Il Hwang · University Of California At Davis · R37 · FY2025 · CA
Regulation of metastasis by alpha V integrin and Src
$354,968David A Cheresh · University Of California, San Diego · R01 · FY2009 · CA
Exploiting gold nanoparticle as a probe to identify therapeutic targets
$354,959Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA
PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE I-CORP OPTION
$354,959Ehsan Yazdi · Nomocan Pharmaceuticals, Llc · N43 · FY2023 · CA
SBIR Concept award for A novel delivery approach to transform metastatic pancreatic cancer treatment and prevention
$354,941Yang David Lee · Pathcision Medicine, Inc. · N43 · FY2025 · CA
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
$354,825Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Development of a Novel High-Throughput Screening Platform for BK Channel Modulato
$354,804Frank T Horrigan · Baylor College Of Medicine · R01 · FY2013 · GM
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
$354,608Oliver Gene McDonald · University Of Miami School Of Medicine · R01 · FY2023 · CA